Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07679074 · ClinicalTrials.gov registry record
CREST: Samphire Guided Care Program on Wellbeing, Work Productivity, and Quality of Life
A clinical trial, sponsored by Samphire Group.
- Recruiting
- Registry status
- 50
- Enrollment target
NCT07679074 is a clinical trial that is actively recruiting participants, run by Samphire Group. The registered enrollment target is 50 participants.
The verdict
NCT07679074 is actively recruiting participants, sponsored by Samphire Group.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
Study Summary
This study evaluates the feasibility and efficacy of the Samphire Guided Care (SGC) program * a 12-week structured digital health program combining clinician-led onboarding, at-home neuromodulation using the Lutea tDCS device, neuromodulation coach support, and app-based symptom tracking - on work productivity, employee wellbeing, and quality of life in individuals experiencing mood and cognitive symptoms associated with menstruation, perimenopause, or menopause.
Interventions
- DEVICE Lutea Transcranial Direct Current Stimulation (tDCS) Device
- BEHAVIORAL Samphire Guided Care Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2027-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07679074
The ClinicalTrials.gov registry entry for NCT07679074 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Samphire Group, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lutea Transcranial Direct Current Stimulation (tDCS) Device is the first listed.
NCT07679074 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07679074 about?
NCT07679074 is a clinical study titled "CREST: Samphire Guided Care Program on Wellbeing, Work Productivity, and Quality of Life". This study evaluates the feasibility and efficacy of the Samphire Guided Care (SGC) program * a 12-week structured digital health program combining clinician-led onboarding, at-home neuromodulation using the Lutea tDCS device, neuromodulation coach support, and app-based symptom tracking - on work ...
What is the current status of trial NCT07679074?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2026-06-01. Estimated completion is 2027-03-01.
What interventions are being tested in trial NCT07679074?
The interventions under investigation include: Lutea Transcranial Direct Current Stimulation (tDCS) Device (DEVICE), Samphire Guided Care Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT07679074?
This trial is sponsored by Samphire Group, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.